Abstract
A 74-year-old woman was experiencing rheumatoid arthritis complicated with interstitial pneumonitis (IP), and tacrolimus treatment was started. She presented with dyspnea. Chest X-ray and computed tomography (CT) showed ground-glass opacity and IP. Although tacrolimus was stopped, she died of respiratory failure. At autopsy, both the upper and lower lung fields showed usual IP and the organizing stage of diffuse alveolar damage. The former is common, but the latter is uncommon, suggesting tacrolimus may cause severe alveolar damage.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Villanueva J, Boukhamseen A, Bhorade SM. Successful use in lung transplantation of an immunosuppressive regimen aimed at reducing target blood levels of sirolimus and tacrolimus. J Heart Lung Transplant. 2005;24:421–5.
Lo A, Egidi MF, Gaber LW, Shokouh-Amiri MH, Nazakatgoo N, Fisher JS et al. Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation. Clin Transplant. 2004;18:53–61.
Yocum DE, Furst DE, Bensen WG, Burch FX, Borton MA, Menqle-Gaw LJ et al. Safety of tacrolimus in patient with rheumatoid arthritis: long-term experience. Rheumatology. 2004;43:992–9.
Kondo H, Abe T, Hashimoto H, Uchida S, Irimajiri S, Hara M et al. Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double-blind, placebo controlled dose-finding study. J Rheumatol. 2004;31:243–51.
Wenzel J, Montag S, Wilsmann-Theis D, Gaffal E, Bieber T, Tuting T. Successful treatment of recalcitrant Wegener’s granulomatous of the skin with tacrolimus (Prograf). Br J Dermatol. 2004;151:927–8.
Bongartz T, Ryu JH, Matteson EL. Is tacrolimus effective for treating antisynthetase-associated interstitial lung disease? Nat Clin Pract Rheumatol. 2005;1:80–1.
Ochi S, Nanki T, Takada K, Suzuki F, Komano Y, Kubota T et al. Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomyositis. Clin Exp Rheumatol. 2005;23:707–10.
Magari K, Miyata S, Ohkubo Y, Mutoh S. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T-cell activation. Inflamm Res. 2004;53:469–74.
Magari K, Miyata S, Nishigaki F, Ohkubo Y, Mutoh S, Goto T. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis. J Rheumatol. 2003;30:2193–200.
Schmidt RH, Lenz T, Grone HJ, Geiqur H, Scheuermann EH. Haemolytic-ureamic syndrome after tacrolimus rescue therapy for cortisone-resistant rejection. Nephrol Dial Transplant. 1999;14:979–83.
Przepiorka D, Abu-Elmagd K, Huaringa A, Luna M, van Besian K, Starzl TE et al. Bronchiolitis obliterans oeganizing pneumonia in a BMT patient receiving FK506. Bone Marrow Transplant. 1993;11:502.
Enomoto T, Azuma A, Murata A, Taniguchi Y, Nakahiro K, Takahashi T et al. Analysis of pulmonary manifestation in patients with rheumatoid arthritis. Arerugi. 1997;46:1156–62.
Okuda Y, Takasugi K, Imai A, Oyama T, Oyama H, Kawamura S. Clinical study of rheumatoid interstitial lung disease evaluated by high resolution CT. Ryumachi. 1993;33:12–9.
American Thoracic Society, European Respiratory Society. ATS/ERS International consensus statement: idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respire Crit Care Med. 2000;161:646–64.
Conflict of interest statement
This article does not contribute to any conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Miwa, Y., Isozaki, T., Wakabayashi, K. et al. Tacrolimus-induced lung injury in a rheumatoid arthritis patient with interstitial pneumonitis. Mod Rheumatol 18, 208–211 (2008). https://doi.org/10.1007/s10165-008-0034-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-008-0034-3